EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Transcriptomics of interstitial lung disease: a systematic review and meta-analysis

Daniel He iD, Sabina A Guler iD, Casey P Shannon iD, Christopher J Ryerson, Scott J Tebbutt iD

European Respiratory Journal · 2025

DOI: 10.1183/13993003.01070-2024 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Respiratory Journal, 2025. Verfasst von Daniel He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Transcriptome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gene expression (transcriptomics) studies have revealed potential mechanisms of interstitial lung disease, yet sample sizes of studies are often limited and between-subtype comparisons are scarce. The aim of this study was to identify and validate consensus transcriptomic signatures of interstitial lung disease subtypes.

Methods

We performed a systematic review and meta-analysis of fibrotic interstitial lung disease transcriptomics studies using an individual participant data approach. We included studies examining bulk transcriptomics of human adult interstitial lung disease samples and excluded those focusing on individual cell populations. Patient-level data and expression matrices were extracted from 43 studies and integrated using a multivariable integrative algorithm to develop interstitial lung disease classification models.

Results

Using 1459 samples from 24 studies, we identified transcriptomic signatures for idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia and systemic sclerosis-associated interstitial lung disease against control samples, which were validated on 308 samples from eight studies (idiopathic pulmonary fibrosis area under receiver operating curve (AUC) 0.99, 95% CI 0.99–1.00; hypersensitivity pneumonitis AUC 0.91, 95% CI 0.84–0.99; nonspecific interstitial pneumonia AUC 0.94, 95% CI 0.88–0.99; systemic sclerosis-associated interstitial lung disease AUC 0.98, 95% CI 0.93–1.00). Significantly, meta-analysis allowed us to identify, for the first time, robust lung transcriptomics signatures to discriminate idiopathic pulmonary fibrosis (AUC 0.71, 95% CI 0.63–0.79) and hypersensitivity pneumonitis (AUC 0.76, 95% CI 0.63–0.89) from other fibrotic interstitial lung disease, and unsupervised learning algorithms identified putative molecular endotypes of interstitial lung disease associated with decreased forced vital capacity and diffusing capacity of the lungs for carbon monoxide % predicted. Transcriptomics signatures were reflective of both cell-specific and disease-specific changes in gene expression.

Conclusion

We present the first systematic review and largest meta-analysis of fibrotic interstitial lung disease transcriptomics to date, identifying reproducible transcriptomic signatures with clinical relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialTranscriptomeHumansAlveolitis, Extrinsic AllergicGene Expression ProfilingIdiopathic Pulmonary FibrosisROC CurveScleroderma, Systemic

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.
  • Prevention of Organ Failure (PROOF) Centre of Excellence, Providence Research, Vancouver, BC, Canada.
  • Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Lung Precision Medicine (LPM), Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
  • C.J. Ryerson and S.J. Tebbutt contributed equally to this article as lead authors and supervised the work.

ORCID-Profile: Daniel He, Sabina A Guler, Casey P Shannon, Scott J Tebbutt

Zitieren

APA

He, D., Guler, S. A., Shannon, C. P., Ryerson, C. J., & Tebbutt, S. J. (2025). Transcriptomics of interstitial lung disease: a systematic review and meta-analysis. European Respiratory Journal. https://doi.org/10.1183/13993003.01070-2024

Vancouver

He D, Guler SA, Shannon CP, Ryerson CJ, Tebbutt SJ. Transcriptomics of interstitial lung disease: a systematic review and meta-analysis. European Respiratory Journal. 2025. doi:10.1183/13993003.01070-2024

BibTeX
@article{He2025,
  author = {He, Daniel and Guler, Sabina A and Shannon, Casey P and Ryerson, Christopher J and Tebbutt, Scott J},
  title = {Transcriptomics of interstitial lung disease: a systematic review and meta-analysis},
  journal = {European Respiratory Journal},
  year = {2025},
  doi = {10.1183/13993003.01070-2024}
}
Kostenlos starten →